Vident Investment Advisory, LLC Adaptive Biotechnologies Corp Transaction History

Vident Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $15,933 - $22,599	2,574 Added 16.2%	18,467 $123,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $5,725 - $7,420	734 Added 4.84%	15,893 $140,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $11,712 - $17,475	1,871 Added 14.08%	15,159 $115,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $10,322 - $20,119	1,588 Added 13.57%	13,288 $88,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $74,880 - $172,341	11,700 New	11,700 $92,000
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $154,753 - $205,529	-5,155 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $166,094 - $229,861	5,155 New	5,155 $211,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.